Jun Cheng

3.5k total citations
123 papers, 2.0k citations indexed

About

Jun Cheng is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jun Cheng has authored 123 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 69 papers in Hepatology and 21 papers in Molecular Biology. Recurrent topics in Jun Cheng's work include Hepatitis C virus research (48 papers), Hepatitis B Virus Studies (45 papers) and Liver Disease Diagnosis and Treatment (44 papers). Jun Cheng is often cited by papers focused on Hepatitis C virus research (48 papers), Hepatitis B Virus Studies (45 papers) and Liver Disease Diagnosis and Treatment (44 papers). Jun Cheng collaborates with scholars based in China, United States and Canada. Jun Cheng's co-authors include Lynne E. Maquat, Mirjana Fogel‐Petrovic, Jing Liu, Dong Zhao, Shunai Liu, Zhaosu Wu, Wei Wang, Zhechun Zeng, Jun Liu and Jiayi Sun and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Stroke.

In The Last Decade

Jun Cheng

118 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Cheng China 22 1.1k 672 573 202 166 123 2.0k
Hideto Kawaratani Japan 27 1.3k 1.2× 917 1.4× 756 1.3× 128 0.6× 202 1.2× 136 2.6k
Wei Cai China 26 750 0.7× 482 0.7× 583 1.0× 48 0.2× 138 0.8× 90 1.9k
Lihua Zhu China 25 1.1k 1.1× 338 0.5× 963 1.7× 418 2.1× 264 1.6× 46 2.6k
Danilo Di Bona Italy 33 730 0.7× 537 0.8× 396 0.7× 63 0.3× 100 0.6× 108 2.9k
Kyle E. Brown United States 25 610 0.6× 543 0.8× 570 1.0× 39 0.2× 179 1.1× 79 2.0k
Ashraf Mohamadkhani Iran 23 520 0.5× 330 0.5× 448 0.8× 63 0.3× 219 1.3× 91 1.6k
Gaetano Bertino Italy 25 750 0.7× 845 1.3× 374 0.7× 54 0.3× 175 1.1× 81 2.0k
Noriyuki Takeda Japan 24 1.6k 1.5× 521 0.8× 382 0.7× 352 1.7× 75 0.5× 77 3.0k
Tatsuki Ichikawa Japan 29 1.5k 1.4× 1.3k 1.9× 798 1.4× 128 0.6× 460 2.8× 155 3.2k

Countries citing papers authored by Jun Cheng

Since Specialization
Citations

This map shows the geographic impact of Jun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Cheng more than expected).

Fields of papers citing papers by Jun Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Cheng. The network helps show where Jun Cheng may publish in the future.

Co-authorship network of co-authors of Jun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Cheng. A scholar is included among the top collaborators of Jun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Cheng. Jun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Xiaobo, Wen Xie, Yanbin Wang, et al.. (2025). Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
2.
Yuan, Xiaoxue, Ming Han, Yun Wang, et al.. (2024). TRPV4 promotes HBV replication and capsid assembly via methylation modification of H3K4 and HBc ubiquitin. Journal of Medical Virology. 96(4). e29510–e29510. 4 indexed citations
3.
He, Qiufeng, et al.. (2024). Dynamic Changes of Growth and Thyroid Function in Young Children With Chronic Hepatitis B Treated With Peginterferon Monotherapy. The Pediatric Infectious Disease Journal. 44(2). 112–117.
5.
Liu, Chen, et al.. (2023). Systematic review and meta-analysis: Efficacy and safety of baclofen in patients with alcohol use disorder co-morbid liver diseases. Journal of Psychiatric Research. 164. 477–484. 7 indexed citations
6.
Feng, Gong, et al.. (2023). Potential of PAQosome as a therapeutic target for hepatic fibrosis. Journal of Gastroenterology and Hepatology. 39(2). 381–391.
7.
Yan, Xiaofeng, et al.. (2020). Tuberculosis Infection Control Project Management Experience and Its Application in COVID-19 Response. China CDC Weekly. 2(34). 666–668. 2 indexed citations
8.
Lun, Yongzhi, Zhipeng Pan, Jie Sun, et al.. (2020). The peptide encoded by a novel putative lncRNA HBVPTPAP inducing the apoptosis of hepatocellular carcinoma cells by modulating JAK/STAT signaling pathways. Virus Research. 287. 198104–198104. 29 indexed citations
9.
Zhou, Li, Shunai Liu, Ming Han, et al.. (2017). miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis. Molecular Therapy — Nucleic Acids. 10. 91–102. 32 indexed citations
10.
Wang, Yan, Xieer Liang, Hui Wang, et al.. (2017). Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B. Journal of Viral Hepatitis. 25(5). 598–607. 5 indexed citations
11.
Hou, Jinlin, Guiqiang Wang, Fu‐Sheng Wang, et al.. (2017). Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology. 5(4). 297–318. 202 indexed citations
12.
Li, Minghui, Lu Zhang, Yao Lu, et al.. (2016). Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2a. World Journal of Hepatology. 8(15). 637–637. 23 indexed citations
14.
Lun, Yongzhi, et al.. (2014). Transactivation of proto-oncogene c-Myc by hepatitis B virus transactivator MHBst167. Oncology Letters. 8(2). 803–808. 4 indexed citations
15.
Xie, Wen, Guangfeng Shi, Hongfei Zhang, et al.. (2011). A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol. Hepatology International. 6(2). 441–448. 14 indexed citations
16.
Zhong, Yanwei, Jiong Cai, Chuanfu Zhang, et al.. (2011). Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A. Virology Journal. 8(1). 542–542. 10 indexed citations
17.
Che, Nanying, Song Li, Zhiguo Zhang, et al.. (2010). Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clinica Chimica Acta. 411(21-22). 1645–1649. 47 indexed citations
18.
Wang, Z., Jinlin Hou, G. Zeng, et al.. (2006). Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China*. Journal of Viral Hepatitis. 14(6). 426–434. 34 indexed citations
19.
20.
Cheng, Jun, Ke Li, Yinying Lu, et al.. (2002). Cloning and expression of the gene of augmenter of liver regeneration in yeast cells.. PubMed. 1(1). 87–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026